Global and gene-specific promoter methylation analysis in primary hyperparathyroidism

References

• DeLellis RA, Lloyd RV, Heitz PU, C E. Pathology and Genetics of the Tumours of Endocrine Organs, WHO Classification of Tumours. Lyon: IARC Press, 2004.
   Google Scholar
• Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276:404 - 7; http://dx.doi.org/10.1126/science.276.5311.404; PMID: 9103196
   PubMed Web of Science ®Google Scholar
• Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 1997; 6:1177 - 83; http://dx.doi.org/10.1093/hmg/6.7.1177; PMID: 9215690
   PubMed Web of Science ®Google Scholar
• Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002; 32:676 - 80; http://dx.doi.org/10.1038/ng1048; PMID: 12434154
   PubMed Web of Science ®Google Scholar
• Carling T, Rastad J, Szabó E, Westin G, Akerström G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85:2000 - 3; http://dx.doi.org/10.1210/jc.85.5.2000; PMID: 10843188
   PubMed Web of Science ®Google Scholar
• Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997; 51:328 - 36; http://dx.doi.org/10.1038/ki.1997.41; PMID: 8995751
   PubMed Web of Science ®Google Scholar
• Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 2000; 85:2042 - 7; http://dx.doi.org/10.1210/jc.85.5.2042; PMID: 10843194
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457 - 63; http://dx.doi.org/10.1038/nature02625; PMID: 15164071
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
   PubMed Web of Science ®Google Scholar
• Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16:168 - 74; http://dx.doi.org/10.1016/S0168-9525(99)01971-X; PMID: 10729832
   PubMed Web of Science ®Google Scholar
• Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22:4632 - 42; http://dx.doi.org/10.1200/JCO.2004.07.151; PMID: 15542813
   PubMed Web of Science ®Google Scholar
• Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, et al. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS One 2010; 5:e9472; http://dx.doi.org/10.1371/journal.pone.0009472; PMID: 20208994
   PubMedGoogle Scholar
• Starker LF, Svedlund J, Udelsman R, Dralle H, Akerström G, Westin G, et al. The DNA methylome of benign and malignant parathyroid tumors. Genes Chromosomes Cancer 2011; 50:735 - 45; http://dx.doi.org/10.1002/gcc.20895; PMID: 21638518
   PubMed Web of Science ®Google Scholar
• Hewitt KM, Sharma PK, Samowitz W, Hobbs M. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma. Ann Otol Rhinol Laryngol 2007; 116:928 - 33; PMID: 18217513
   PubMed Web of Science ®Google Scholar
• Hahn MA, Howell VM, Gill AJ, Clarkson A, Weaire-Buchanan G, Robinson BG, et al. CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer 2010; 17:273 - 82; http://dx.doi.org/10.1677/ERC-09-0291; PMID: 20026646
   PubMed Web of Science ®Google Scholar
• Sulaiman L, Haglund F, Hashemi J, Obara T, Nordenström J, Larsson C, et al. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors. PLoS One 2012; 7:e46325; http://dx.doi.org/10.1371/journal.pone.0046325; PMID: 23029479
   PubMedGoogle Scholar
• Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A. CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 2003; 22:924 - 34; http://dx.doi.org/10.1038/sj.onc.1206123; PMID: 12584572
   PubMed Web of Science ®Google Scholar
• Di Vinci A, Perdelli L, Banelli B, Salvi S, Casciano I, Gelvi I, et al. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer 2005; 114:414 - 21; http://dx.doi.org/10.1002/ijc.20771; PMID: 15578730
   PubMed Web of Science ®Google Scholar
• Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123:161 - 7; http://dx.doi.org/10.1002/ijc.23519; PMID: 18398837
   PubMed Web of Science ®Google Scholar
• Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003; 9:3635 - 40; PMID: 14506151
   PubMed Web of Science ®Google Scholar
• Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93:691 - 9; http://dx.doi.org/10.1093/jnci/93.9.691; PMID: 11333291
   PubMed Web of Science ®Google Scholar
• Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007; 17:45 - 51; http://dx.doi.org/10.1016/j.gde.2006.12.007; PMID: 17208432
   PubMed Web of Science ®Google Scholar
• Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Bränström R, et al. Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas. Int J Oncol 2009; 34:481 - 92; PMID: 19148484
   PubMed Web of Science ®Google Scholar
• Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36:417 - 22; http://dx.doi.org/10.1038/ng1330; PMID: 15034581
   PubMed Web of Science ®Google Scholar
• Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, et al. Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 2009; 18:2694 - 700; http://dx.doi.org/10.1158/1055-9965.EPI-08-0821; PMID: 19789364
   PubMed Web of Science ®Google Scholar
• Costa VL, Henrique R, Ribeiro FR, Carvalho JR, Oliveira J, Lobo F, et al. Epigenetic regulation of Wnt signaling pathway in urological cancer. Epigenetics 2010; 5:343 - 51; http://dx.doi.org/10.4161/epi.5.4.11749; PMID: 20421722
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89 - 92; http://dx.doi.org/10.1038/301089a0; PMID: 6185846
   PubMed Web of Science ®Google Scholar
• Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; 2:Suppl 1 S4 - 11; http://dx.doi.org/10.1038/ncponc0354; PMID: 16341240
   PubMedGoogle Scholar
• Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005; 45:629 - 56; http://dx.doi.org/10.1146/annurev.pharmtox.45.120403.095832; PMID: 15822191
   PubMed Web of Science ®Google Scholar
• Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012; 22:50 - 5; http://dx.doi.org/10.1016/j.gde.2012.02.008; PMID: 22402447
   PubMed Web of Science ®Google Scholar
• Gavert N, Ben-Ze’ev A. beta-Catenin signaling in biological control and cancer. J Cell Biochem 2007; 102:820 - 8; http://dx.doi.org/10.1002/jcb.21505; PMID: 17854061
   PubMed Web of Science ®Google Scholar
• Zeki K, Spambalg D, Sharifi N, Gonsky R, Fagin JA. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms. J Clin Endocrinol Metab 1994; 79:1317 - 21; http://dx.doi.org/10.1210/jc.79.5.1317; PMID: 7962323
   PubMed Web of Science ®Google Scholar
• Hayes MJ, Thomas D, Emmons A, Giordano TJ, Kleer CG. Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res 2008; 14:4038 - 44; http://dx.doi.org/10.1158/1078-0432.CCR-07-4379; PMID: 18593979
   PubMed Web of Science ®Google Scholar
• Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 2001; 7:1998 - 2004; PMID: 11448917
   PubMed Web of Science ®Google Scholar
• Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000; 60:4366 - 71; PMID: 10969779
   PubMed Web of Science ®Google Scholar
• Björklund P, Akerström G, Westin G. Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. J Clin Endocrinol Metab 2007; 92:338 - 44; http://dx.doi.org/10.1210/jc.2006-1197; PMID: 17047023
   PubMed Web of Science ®Google Scholar
• Cetani F, Pardi E, Banti C, Collecchi P, Viacava P, Borsari S, et al. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas. Endocr Relat Cancer 2010; 17:1 - 6; http://dx.doi.org/10.1677/ERC-09-0147; PMID: 19755524
   PubMed Web of Science ®Google Scholar
• Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992; 52:741 - 5; PMID: 1346256
   PubMed Web of Science ®Google Scholar
• Zhang HY, Rumilla KM, Jin L, Nakamura N, Stilling GA, Ruebel KH, et al. Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors. Endocrine 2006; 30:299 - 306; http://dx.doi.org/10.1007/s12020-006-0008-1; PMID: 17526942
   PubMed Web of Science ®Google Scholar
• Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65:3497 - 508; http://dx.doi.org/10.1158/0008-5472.CAN-04-4088; PMID: 15867337
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. Methylation of the RASSF1A gene in human cancers. Biol Chem 2002; 383:907 - 14; http://dx.doi.org/10.1515/BC.2002.097; PMID: 12222680
   PubMed Web of Science ®Google Scholar
• Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315 - 9; http://dx.doi.org/10.1038/77083; PMID: 10888881
   PubMed Web of Science ®Google Scholar
• Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001; 20:1509 - 18; http://dx.doi.org/10.1038/sj.onc.1204175; PMID: 11313894
   PubMed Web of Science ®Google Scholar
• Li J, El-Naggar A, Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 2005; 104:771 - 6; http://dx.doi.org/10.1002/cncr.21215; PMID: 15959912
   PubMed Web of Science ®Google Scholar
• Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, et al. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007; 26:5680 - 91; http://dx.doi.org/10.1038/sj.onc.1210345; PMID: 17353908
   PubMed Web of Science ®Google Scholar
• Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006; 25:3479 - 88; http://dx.doi.org/10.1038/sj.onc.1209386; PMID: 16449975
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
   PubMed Web of Science ®Google Scholar
• Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286 - 98; http://dx.doi.org/10.1038/nrg2005; PMID: 17339880
   PubMed Web of Science ®Google Scholar
• Sulaiman L, Nilsson IL, Juhlin CC, Haglund F, Höög A, Larsson C, et al. Genetic characterization of large parathyroid adenomas. Endocr Relat Cancer 2012; 19:389 - 407; http://dx.doi.org/10.1530/ERC-11-0140; PMID: 22454399
   PubMed Web of Science ®Google Scholar
• Rosen JE, Costouros NG, Lorang D, Burns AL, Alexander HR, Skarulis MC, et al. Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas. Ann Surg Oncol 2005; 12:412 - 6; http://dx.doi.org/10.1245/ASO.2005.03.103; PMID: 15915376
   PubMed Web of Science ®Google Scholar
• Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L, et al. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 2007; 14:501 - 12; http://dx.doi.org/10.1677/ERC-07-0021; PMID: 17639063
   PubMed Web of Science ®Google Scholar
• Sulaiman L, Nilsson IL, Juhlin CC, Haglund F, Höög A, Larsson C, et al. Genetic characterization of large parathyroid adenomas. Endocr Relat Cancer 2012; 19:389 - 407; http://dx.doi.org/10.1530/ERC-11-0140; PMID: 22454399
   PubMed Web of Science ®Google Scholar
• Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003; 349:1722 - 9; http://dx.doi.org/10.1056/NEJMoa031237; PMID: 14585940
   PubMed Web of Science ®Google Scholar
• Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, et al. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 2006; 13:509 - 23; http://dx.doi.org/10.1677/erc.1.01058; PMID: 16728578
   PubMed Web of Science ®Google Scholar